Form 4: Cardlytics Director Jessica Jensen Reports Stock Transactions

Director Jessica Jensen reports the acquisition and disposal of Cardlytics (CDLX) common stock related to restricted stock units.

Summary

• On May 23, 2024, Jessica Jensen, a director of Cardlytics, Inc. (CDLX), reported transactions involving the company's common stock.
• Jensen acquired 28,547 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
• Simultaneously, Jensen disposed of 28,547 shares.
• Following these transactions, Jensen directly owns 38,606 shares of Cardlytics common stock.
• The RSUs vested in full on the one-year anniversary of the grant date.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine stock activity by a company director.

Key Dates